Sandoz Recalls Losartan Potassium and Ezetimibe Prescription Drug Bottles due to Packaging Issues

Shots:

• Sandoz recalls ~636,000 of Losartan potassium and Ezetimibe prescription drug bottles due to failure to meet child-resistant closure requirements as required by the Poison Prevention Packaging Act, posing a poisoning risk if swallowed by children
• The products affected by the recall has distributed by Sandoz in the US includes Ezetimibe in 10mg tablets in 30 and 90 count bottles with its affected NDC numbers are # 0781-5690-31 (30 tablets) and # 0781-5690-92 (90 tablets) and Losartan potassium in 50mg in 30 count bottles with NDC number # 0781-5701-31
• The affected lot was sold at clinics & pharmacies from Jul’18 to Aug’19. Consumers or pharmacies can contact Sandoz at  www.us.sandoz.com or 1-800-525-8747  for a free replacement child-resistant bottle cap and can continue the medication, once the medication is secured

Click here to­ read full press release/ article | Ref: PRNewswire | Image: WUSA9